MOLECULE CAPABLE OF BINDING TO HUMAN 4-1BB AND ITS APPLICATION THEREOF

A molecule capable of binding to human 4-1BB includes the amino acid sequences of HCDR1, HCDR2 and HCDR3 in the heavy chain variable region of the antibody provided by present invention are shown sequentially at positions 31-35, positions 50-64, and positions 98-106 in SEQ ID No.1 from the N-terminu...

Full description

Saved in:
Bibliographic Details
Main Authors ZENG, Xiaoli, CHENG, Liansheng, WANG, Fengrong, ZHANG, Dayan, LIU, Wenting
Format Patent
LanguageEnglish
Published 29.12.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A molecule capable of binding to human 4-1BB includes the amino acid sequences of HCDR1, HCDR2 and HCDR3 in the heavy chain variable region of the antibody provided by present invention are shown sequentially at positions 31-35, positions 50-64, and positions 98-106 in SEQ ID No.1 from the N-terminus. The amino acid sequences of LCDR1, LCDR2 and LHCDR3 in the light chain variable region are shown sequentially at positions 24-34, positions 50-56, and positions 89-97 in SEQ ID No.2 from the N-terminus. The antibodies provided by the present invention can bind to human and monkey 4-1BB, exhibit high affinity to human 4-1BB and effectively enhance T cell responses; they can be used to regulate the immune responses mediated by T cells and antibodies; as immune modulators, they have a wide range of therapeutic uses in diseases such as cancer, autoimmune diseases, inflammatory diseases, and infectious diseases, etc.
AbstractList A molecule capable of binding to human 4-1BB includes the amino acid sequences of HCDR1, HCDR2 and HCDR3 in the heavy chain variable region of the antibody provided by present invention are shown sequentially at positions 31-35, positions 50-64, and positions 98-106 in SEQ ID No.1 from the N-terminus. The amino acid sequences of LCDR1, LCDR2 and LHCDR3 in the light chain variable region are shown sequentially at positions 24-34, positions 50-56, and positions 89-97 in SEQ ID No.2 from the N-terminus. The antibodies provided by the present invention can bind to human and monkey 4-1BB, exhibit high affinity to human 4-1BB and effectively enhance T cell responses; they can be used to regulate the immune responses mediated by T cells and antibodies; as immune modulators, they have a wide range of therapeutic uses in diseases such as cancer, autoimmune diseases, inflammatory diseases, and infectious diseases, etc.
Author WANG, Fengrong
CHENG, Liansheng
LIU, Wenting
ZENG, Xiaoli
ZHANG, Dayan
Author_xml – fullname: ZENG, Xiaoli
– fullname: CHENG, Liansheng
– fullname: WANG, Fengrong
– fullname: ZHANG, Dayan
– fullname: LIU, Wenting
BookMark eNqNyj0OwiAUAGAGHfy7w0ucmwitB3hQEBIKjYW5acxzMrRJvX908ABO3_Lt2abMhXbMdNFrlb0GhT3Kr9GAdKF14QYpgs0dBmgqLiVgaMGlAbDvvVOYXAyQrL7raI5s-5xeK51-HtjZ6KRsRcs80rpMDyr0HvMgLkI0nF9Fjbz-b30AEoYuDw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022411523A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022411523A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:42:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022411523A13
Notes Application Number: US202017774972
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&CC=US&NR=2022411523A1
ParticipantIDs epo_espacenet_US2022411523A1
PublicationCentury 2000
PublicationDate 20221229
PublicationDateYYYYMMDD 2022-12-29
PublicationDate_xml – month: 12
  year: 2022
  text: 20221229
  day: 29
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Hefei Hankemab Biotechnology Co., LTD
RelatedCompanies_xml – name: Hefei Hankemab Biotechnology Co., LTD
Score 3.4487298
Snippet A molecule capable of binding to human 4-1BB includes the amino acid sequences of HCDR1, HCDR2 and HCDR3 in the heavy chain variable region of the antibody...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title MOLECULE CAPABLE OF BINDING TO HUMAN 4-1BB AND ITS APPLICATION THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221229&DB=EPODOC&locale=&CC=US&NR=2022411523A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDZW3Fbs7Z7GNKmqZ2sH2yt7G00XQaCdMNV_Pe9hk33tKd8HDmSwH38ktwF4EmYUu_IzNSMhZVpFLWwJnTR1XTaWVIDh5gqKi0IDT-lb7P-rAafu1gYlSf0RyVHRInKUd5Lpa_X_4dYrnpbuXkWH9i1evGSodveouMeKmIE0K4z5HHkRqzN2DCdtsOJolH0fnq6jVjpqHKkq0z7_N2p4lLW-0bFO4fjGPkV5QXUZNGAU7b7e60BJ8H2yhurW-nbXIIXRGPO0jEnzI5tB8vII84odEfhK0ki4qeBHRKqdR2H2KFLRsmU2HG8CxYmic8nPPKu4NHjCfM1nND8b_3zdLo_e_0a6sWqkDdAEAsYom8sLQSaNBtYmcwzXfYzalqDhZWLJrQOcbo9TL6Ds6pZvd3oDVpQL7--5T1a4FI8qI37Bet3gpU
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQFlb8VtzdruYUibtrbapmVrZW-j7TIQpBuu4r_vLWy6pz0l5MhxCdxdfsndBeAx14XaEZmuaDMjUyhaYSVX866i0s6cajhFl1lpIde8lL5O-pMafG5zYWSd0B9ZHBE1qkB9r6S9Xv5fYtkytnL1lH_g0OLZTYZ2e4OOe2iIEUDb1tCJIztibcaG6bjNR5JG8fTTU03ESgc6gkIJlt6tdV7KctepuCdwGCO_sjqFmiib0GDbv9eacBRunryxu9G-1Rm4YRQ4LA0cwszYtLCNXGL53Pb5C0ki4qWhyQlVupZFTG4TPxkTM463ycIk8ZyRE7nn8OA6CfMUFGj6t_5pOt6VXr2AerkoxSUQxAJa3tfmBgJNmg2MTBSZKvoZ1Y3BzCjyK2jt43S9n3wPDS8Jg2ng87cbOF6T1nEcvUEL6tXXt7hFb1zld3ITfwEriIV_
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MOLECULE+CAPABLE+OF+BINDING+TO+HUMAN+4-1BB+AND+ITS+APPLICATION+THEREOF&rft.inventor=ZENG%2C+Xiaoli&rft.inventor=CHENG%2C+Liansheng&rft.inventor=WANG%2C+Fengrong&rft.inventor=ZHANG%2C+Dayan&rft.inventor=LIU%2C+Wenting&rft.date=2022-12-29&rft.externalDBID=A1&rft.externalDocID=US2022411523A1